English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduMore than two-thirds of people taking blood thinners take direct oral anticoagulants, or DOACs, which are under- or over-prescribed in up to one in eight patients. A new study finds that most prescribing issues for DOACs occur after a provider writes the initial prescription. Researchers say the findings highlight why patients on DOACs need to be monitored consistently.
Tag: Blood Thinner
Stroke, Clot Risk Halved in Heart Disease and Arrhythmia Patients Who Took Blood Thinners Apixaban Versus Rivaroxaban
The new study showed apixaban is superior to rivaroxaban against stroke or systemic embolism in patients with atrial fibrillation and valvular heart disease
The Medical Minute: Reducing stroke risk from AFib without blood thinners
To help prevent a stroke — a common and serious risk associated with AFib — patients are treated with blood thinners. But for some, the medication itself can be risky.
Canadian-led international study: Full-dose blood thinners benefit moderately ill COVID-19 patients
The investigators discovered that in moderately ill patients full-dose heparin reduced the need for organ support compared to those who received lower-dose heparin.
Two Blood Thinners at Once: More Risk with the Same Reward
For some patients, adding aspirin to a direct oral anticoagulant is an equation that rarely adds up.
Benefits of High-dose Blood Thinners in COVID-19 Patients Remain Unclear
While COVID-19 infected patients should be treated with standard anticoagulation therapies, such as blood thinning medication, a new study by researchers at the George Washington University shows that anticoagulating patients at higher doses, without traditional medical indications to do so, may be ineffective and even harmful.
Mount Sinai Team Offers Additional Data on Efficacy of Blood Thinners for COVID-19 and Insight on Best Potential Regimens
Study is the basis of a new international clinical trial
Treating PE: How Safe and Effective Are New Devices?
A new scientific statement from the American Heart Association identifies the risks and benefits of using novel interventional devices compared to anticoagulation alone to treat patients with pulmonary embolism.
Treating Pulmonary Embolism: How Safe and Effective Are New Devices?
A new scientific statement from the American Heart Association identifies the risks and benefits of using novel interventional devices compared to anticoagulation alone to treat patients with pulmonary embolism.